Detalhe da pesquisa
1.
Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells.
Mol Cell
; 81(17): 3637-3649.e5, 2021 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478654
2.
High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical Models.
Cancer Immunol Res
; 12(4): 462-477, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38345397
3.
Harnessing type I CRISPR-Cas systems for genome engineering in human cells.
Nat Biotechnol
; 37(12): 1471-1477, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740839